annual operating expenses:
$440.77M+$10.31M(+2.40%)Summary
- As of today (May 24, 2025), BCRX annual total operating expenses is $440.77 million, with the most recent change of +$10.31 million (+2.40%) on December 31, 2024.
- During the last 3 years, BCRX annual operating expenses has risen by +$113.14 million (+34.53%).
- BCRX annual operating expenses is now at all-time high.
Performance
BCRX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$119.74M-$10.17M(-7.83%)Summary
- As of today (May 24, 2025), BCRX quarterly total operating expenses is $119.74 million, with the most recent change of -$10.17 million (-7.83%) on March 31, 2025.
- Over the past year, BCRX quarterly operating expenses has increased by +$13.76 million (+12.98%).
- BCRX quarterly operating expenses is now -10.93% below its all-time high of $134.43 million, reached on December 31, 2023.
Performance
BCRX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BCRX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.4% | +13.0% |
| 3 y3 years | +34.5% | +20.2% |
| 5 y5 years | +205.7% | +161.8% |
BCRX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.5% | -10.9% | +33.5% |
| 5 y | 5-year | at high | +205.7% | -10.9% | +189.4% |
| alltime | all time | at high | >+9999.0% | -10.9% | +2760.9% |
BCRX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $119.74M(-7.8%) |
| Dec 2024 | $440.77M(+2.4%) | $129.91M(+22.4%) |
| Sep 2024 | - | $106.17M(+7.4%) |
| Jun 2024 | - | $98.84M(-6.7%) |
| Mar 2024 | - | $105.98M(-21.2%) |
| Dec 2023 | $430.46M(+4.3%) | $134.43M(+37.8%) |
| Sep 2023 | - | $97.53M(-4.6%) |
| Jun 2023 | - | $102.24M(+6.2%) |
| Mar 2023 | - | $96.25M(-22.0%) |
| Dec 2022 | $412.67M(+26.0%) | $123.36M(+37.6%) |
| Sep 2022 | - | $89.66M(-10.3%) |
| Jun 2022 | - | $100.01M(+0.4%) |
| Mar 2022 | - | $99.64M(+0.7%) |
| Dec 2021 | $327.63M(+71.6%) | $98.92M(+16.4%) |
| Sep 2021 | - | $84.96M(+7.3%) |
| Jun 2021 | - | $79.20M(+22.8%) |
| Mar 2021 | - | $64.51M(+14.5%) |
| Dec 2020 | $190.89M(+32.4%) | $56.34M(+18.8%) |
| Sep 2020 | - | $47.44M(+14.6%) |
| Jun 2020 | - | $41.38M(-9.5%) |
| Mar 2020 | - | $45.73M(+22.7%) |
| Dec 2019 | $144.19M(+26.0%) | $37.26M(+1.1%) |
| Sep 2019 | - | $36.85M(+1.4%) |
| Jun 2019 | - | $36.34M(+7.7%) |
| Mar 2019 | - | $33.73M(+20.8%) |
| Dec 2018 | $114.40M(+41.4%) | $27.92M(-6.7%) |
| Sep 2018 | - | $29.93M(-1.9%) |
| Jun 2018 | - | $30.50M(+17.1%) |
| Mar 2018 | - | $26.05M(+20.5%) |
| Dec 2017 | $80.89M(+11.9%) | $21.62M(+3.7%) |
| Sep 2017 | - | $20.85M(+12.1%) |
| Jun 2017 | - | $18.59M(-6.2%) |
| Mar 2017 | - | $19.83M(+34.7%) |
| Dec 2016 | $72.26M(-15.8%) | $14.72M(-12.7%) |
| Sep 2016 | - | $16.86M(-0.2%) |
| Jun 2016 | - | $16.89M(-29.0%) |
| Mar 2016 | - | $23.79M(+9.3%) |
| Dec 2015 | $85.81M(+44.8%) | $21.77M(-4.5%) |
| Sep 2015 | - | $22.80M(+13.7%) |
| Jun 2015 | - | $20.06M(-5.3%) |
| Mar 2015 | - | $21.18M(+3.0%) |
| Dec 2014 | $59.26M(+23.6%) | $20.56M(+38.5%) |
| Sep 2014 | - | $14.85M(+13.5%) |
| Jun 2014 | - | $13.08M(+21.4%) |
| Mar 2014 | - | $10.77M(-36.2%) |
| Dec 2013 | $47.95M(-17.7%) | $16.88M(+81.3%) |
| Sep 2013 | - | $9.31M(-28.1%) |
| Jun 2013 | - | $12.96M(+47.4%) |
| Mar 2013 | - | $8.79M(-32.5%) |
| Dec 2012 | $58.29M(-15.8%) | $13.02M(-4.7%) |
| Sep 2012 | - | $13.66M(-5.0%) |
| Jun 2012 | - | $14.39M(-16.5%) |
| Mar 2012 | - | $17.22M(+5.9%) |
| Dec 2011 | $69.23M(-27.6%) | $16.27M(-9.9%) |
| Sep 2011 | - | $18.05M(+0.4%) |
| Jun 2011 | - | $17.98M(+6.2%) |
| Mar 2011 | - | $16.93M(-34.8%) |
| Dec 2010 | $95.62M(+14.1%) | $25.97M(+13.0%) |
| Sep 2010 | - | $22.99M(+28.1%) |
| Jun 2010 | - | $17.95M(-37.5%) |
| Mar 2010 | - | $28.71M(-18.6%) |
| Dec 2009 | $83.78M | $35.27M(+66.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $21.25M(+57.1%) |
| Jun 2009 | - | $13.53M(-1.6%) |
| Mar 2009 | - | $13.75M(-43.7%) |
| Dec 2008 | $83.73M(-19.1%) | $24.44M(+32.3%) |
| Sep 2008 | - | $18.47M(+15.1%) |
| Jun 2008 | - | $16.04M(-35.3%) |
| Mar 2008 | - | $24.78M(-21.6%) |
| Dec 2007 | $103.52M(+94.6%) | $31.60M(-2.2%) |
| Sep 2007 | - | $32.33M(+53.7%) |
| Jun 2007 | - | $21.03M(+108.2%) |
| Mar 2007 | - | $10.10M(-21.3%) |
| Dec 2006 | $53.19M(+94.6%) | $12.83M(-29.7%) |
| Sep 2006 | - | $18.25M(+45.1%) |
| Jun 2006 | - | $12.57M(+31.8%) |
| Mar 2006 | - | $9.54M(+27.0%) |
| Dec 2005 | $27.33M(+23.7%) | $7.51M(-5.7%) |
| Sep 2005 | - | $7.96M(+32.9%) |
| Jun 2005 | - | $5.99M(+2.0%) |
| Mar 2005 | - | $5.87M(+4.7%) |
| Dec 2004 | $22.09M(+54.1%) | $5.61M(+0.7%) |
| Sep 2004 | - | $5.57M(+5.5%) |
| Jun 2004 | - | $5.27M(-6.5%) |
| Mar 2004 | - | $5.64M(+38.1%) |
| Dec 2003 | $14.33M(-23.4%) | $4.09M(+12.6%) |
| Sep 2003 | - | $3.63M(+3.2%) |
| Jun 2003 | - | $3.52M(+13.6%) |
| Mar 2003 | - | $3.10M(-10.8%) |
| Dec 2002 | $18.70M(+15.9%) | $3.47M(-9.3%) |
| Sep 2002 | - | $3.83M(-27.1%) |
| Jun 2002 | - | $5.25M(-14.7%) |
| Mar 2002 | - | $6.16M(+2.2%) |
| Dec 2001 | $16.14M(+22.8%) | $6.03M(+71.2%) |
| Sep 2001 | - | $3.52M(-1.7%) |
| Jun 2001 | - | $3.58M(+9.5%) |
| Mar 2001 | - | $3.27M(-15.3%) |
| Dec 2000 | $13.15M(+18.4%) | $3.86M(+40.5%) |
| Sep 2000 | - | $2.75M(-24.1%) |
| Jun 2000 | - | $3.62M(+15.6%) |
| Mar 2000 | - | $3.13M(+25.2%) |
| Dec 1999 | $11.10M(-14.0%) | $2.50M(-7.4%) |
| Sep 1999 | - | $2.70M(-6.9%) |
| Jun 1999 | - | $2.90M(-6.5%) |
| Mar 1999 | - | $3.10M(+34.8%) |
| Dec 1998 | $12.90M(-7.2%) | $2.30M(-37.8%) |
| Sep 1998 | - | $3.70M(+2.8%) |
| Jun 1998 | - | $3.60M(+5.9%) |
| Mar 1998 | - | $3.40M(-2.9%) |
| Dec 1997 | $13.90M(+28.7%) | $3.50M(+12.9%) |
| Sep 1997 | - | $3.10M(-16.2%) |
| Jun 1997 | - | $3.70M(+362.5%) |
| Mar 1997 | - | $800.00K(-70.4%) |
| Dec 1996 | $10.80M(+285.7%) | $2.70M(-3.6%) |
| Sep 1996 | - | $2.80M(-12.5%) |
| Jun 1996 | - | $3.20M(+52.4%) |
| Mar 1996 | - | $2.10M(-146.7%) |
| Dec 1995 | $2.80M(+12.0%) | -$4.50M(-295.7%) |
| Sep 1995 | - | $2.30M(+21.1%) |
| Jun 1995 | - | $1.90M(-42.4%) |
| Mar 1995 | - | $3.30M(+560.0%) |
| Dec 1994 | $2.50M | $500.00K(-16.7%) |
| Sep 1994 | - | $600.00K(-25.0%) |
| Jun 1994 | - | $800.00K(+14.3%) |
| Mar 1994 | - | $700.00K |
FAQ
- What is BioCryst Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual operating expenses year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly operating expenses year-on-year change?
What is BioCryst Pharmaceuticals annual total operating expenses?
The current annual operating expenses of BCRX is $440.77M
What is the all time high annual operating expenses for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total operating expenses is $440.77M
What is BioCryst Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, BCRX annual total operating expenses has changed by +$10.31M (+2.40%)
What is BioCryst Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of BCRX is $119.74M
What is the all time high quarterly operating expenses for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total operating expenses is $134.43M
What is BioCryst Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, BCRX quarterly total operating expenses has changed by +$13.76M (+12.98%)